[
  {
    "ts": "2026-02-24T07:11:08+00:00",
    "headline": "FDA Approves AbbVie (ABBV) VENCLEXTA and Acalabrutinib Combination for First-Line CLL",
    "summary": "AbbVie Inc. (NYSE:ABBV) is one of the best value stocks to buy now. On February 20, the US FDA approved the combination of VENCLEXTA (venetoclax) and acalabrutinib as a first-line treatment for adults with chronic lymphocytic leukemia/CLL. This establishes the first and only all-oral, fixed-duration regimen for previously untreated patients, providing a new alternative to […]",
    "url": "https://finance.yahoo.com/news/fda-approves-abbvie-abbv-venclexta-071108164.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "893775cf-1617-39f1-b268-520fb5ad30b4",
      "content": {
        "id": "893775cf-1617-39f1-b268-520fb5ad30b4",
        "contentType": "STORY",
        "title": "FDA Approves AbbVie (ABBV) VENCLEXTA and Acalabrutinib Combination for First-Line CLL",
        "description": "",
        "summary": "AbbVie Inc. (NYSE:ABBV) is one of the best value stocks to buy now. On February 20, the US FDA approved the combination of VENCLEXTA (venetoclax) and acalabrutinib as a first-line treatment for adults with chronic lymphocytic leukemia/CLL. This establishes the first and only all-oral, fixed-duration regimen for previously untreated patients, providing a new alternative to […]",
        "pubDate": "2026-02-24T07:11:08Z",
        "displayTime": "2026-02-24T07:11:08Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/1e9120b21df9d4584216be519950b41a",
          "originalWidth": 1280,
          "originalHeight": 853,
          "caption": "FDA Approves AbbVie (ABBV) VENCLEXTA and Acalabrutinib Combination for First-Line CLL",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/fMTKP7t.2d.zV8tkJ89T9A--~B/aD04NTM7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/1e9120b21df9d4584216be519950b41a.cf.webp",
              "width": 1280,
              "height": 853,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/02t2dAWp2fmON9uUD0DVog--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/1e9120b21df9d4584216be519950b41a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/fda-approves-abbvie-abbv-venclexta-071108164.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/fda-approves-abbvie-abbv-venclexta-071108164.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-24T08:48:06+00:00",
    "headline": "AbbVie announces $380m investment in North Chicago API facilities",
    "summary": "Construction is scheduled to commence in spring 2026, with both facilities anticipated to be fully operational by 2029.",
    "url": "https://www.pharmaceutical-technology.com/news/abbvie-investment-north-chicago-api/",
    "source": "Pharmaceutical Technology",
    "provider": "yfinance",
    "raw": {
      "id": "36432201-4adc-3573-a8b4-3648526093e6",
      "content": {
        "id": "36432201-4adc-3573-a8b4-3648526093e6",
        "contentType": "STORY",
        "title": "AbbVie announces $380m investment in North Chicago API facilities",
        "description": "",
        "summary": "Construction is scheduled to commence in spring 2026, with both facilities anticipated to be fully operational by 2029.",
        "pubDate": "2026-02-24T08:48:06Z",
        "displayTime": "2026-02-24T08:48:06Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharmaceutical_technology_376/3dea1bf57e6795685638ae956ca9979a",
          "originalWidth": 1440,
          "originalHeight": 810,
          "caption": "AbbVie employs about 29",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9_7vv5gi86ra5pqqbiGPMg--~B/aD04MTA7dz0xNDQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharmaceutical_technology_376/3dea1bf57e6795685638ae956ca9979a.cf.webp",
              "width": 1440,
              "height": 810,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TUiSFl3SdTbqJhH0JhktAA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharmaceutical_technology_376/3dea1bf57e6795685638ae956ca9979a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharmaceutical Technology",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmaceutical-technology.com/news/abbvie-investment-north-chicago-api/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-announces-380m-investment-north-084806551.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-24T08:48:06+00:00",
    "headline": "AbbVie announces $380m investment in North Chicago API facilities",
    "summary": "Construction is scheduled to commence in spring 2026, with both facilities anticipated to be fully operational by 2029.",
    "url": "https://www.hospitalmanagement.net/news/abbvie-investment-north-chicago-api/",
    "source": "Hospital Management",
    "provider": "yfinance",
    "raw": {
      "id": "bcc9213a-7438-341c-ab85-7b4150cbaabe",
      "content": {
        "id": "bcc9213a-7438-341c-ab85-7b4150cbaabe",
        "contentType": "STORY",
        "title": "AbbVie announces $380m investment in North Chicago API facilities",
        "description": "",
        "summary": "Construction is scheduled to commence in spring 2026, with both facilities anticipated to be fully operational by 2029.",
        "pubDate": "2026-02-24T08:48:06Z",
        "displayTime": "2026-02-24T08:48:06Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/hospital_management_177/3dea1bf57e6795685638ae956ca9979a",
          "originalWidth": 1440,
          "originalHeight": 810,
          "caption": "AbbVie employs about 29",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/s0PHVwJ7I99XuqIwwZO8hg--~B/aD04MTA7dz0xNDQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/hospital_management_177/3dea1bf57e6795685638ae956ca9979a.cf.webp",
              "width": 1440,
              "height": 810,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/owhVLX1_0vw1geWkX3magQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/hospital_management_177/3dea1bf57e6795685638ae956ca9979a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Hospital Management",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.hospitalmanagement.net/news/abbvie-investment-north-chicago-api/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-announces-380m-investment-north-084806709.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-24T13:00:00+00:00",
    "headline": "AbbVie to Present at the TD Cowen 46th Annual Health Care Conference",
    "summary": "AbbVie (NYSE: ABBV) will participate in the TD Cowen 46th Annual Health Care Conference on Tuesday, March 3, 2026. Management will participate in a fireside chat at 10:10 a.m. Central Time.",
    "url": "https://finance.yahoo.com/news/abbvie-present-td-cowen-46th-130000384.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "e5086d80-1cd6-34b1-8228-7b1c96fd0f9b",
      "content": {
        "id": "e5086d80-1cd6-34b1-8228-7b1c96fd0f9b",
        "contentType": "STORY",
        "title": "AbbVie to Present at the TD Cowen 46th Annual Health Care Conference",
        "description": "",
        "summary": "AbbVie (NYSE: ABBV) will participate in the TD Cowen 46th Annual Health Care Conference on Tuesday, March 3, 2026. Management will participate in a fireside chat at 10:10 a.m. Central Time.",
        "pubDate": "2026-02-24T13:00:00Z",
        "displayTime": "2026-02-24T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/1a3de61d36c2bda7ce3a82be5670b967",
          "originalWidth": 16,
          "originalHeight": 16,
          "caption": "Cision",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/UYQyapIz4EQNayV4nwakUQ--~B/aD0xNjt3PTE2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/1a3de61d36c2bda7ce3a82be5670b967.cf.webp",
              "width": 16,
              "height": 16,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pdqugRHMAhMOJcAKAtfLOg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/1a3de61d36c2bda7ce3a82be5670b967.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-present-td-cowen-46th-130000384.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-present-td-cowen-46th-130000384.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "META"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-24T12:01:00+00:00",
    "headline": "Hormone Replacement Therapy Market Competitive Landscape Report 2025: Top Players Analysis, Profiles, Strategic Developments, Mergers, Product Innovations and Launches, Sustainability Goals, Revenues",
    "summary": "The Hormone Replacement Therapy (HRT) market is poised to expand significantly from $23.58 billion in 2025 to $38.18 billion by 2033, driven by a CAGR of 6.21%. Key growth drivers include technological advancements, innovations in delivery methods, and rising cases of hormonal disorders. Increased awareness and acceptance of HRT, largely for menopause-related symptoms in women, alongside supportive government policies, further contribute to market growth. The sector sees immense potential, parti",
    "url": "https://finance.yahoo.com/news/hormone-replacement-therapy-market-competitive-120100685.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "d63b8fe0-f1bf-336c-a247-865f4038fef3",
      "content": {
        "id": "d63b8fe0-f1bf-336c-a247-865f4038fef3",
        "contentType": "STORY",
        "title": "Hormone Replacement Therapy Market Competitive Landscape Report 2025: Top Players Analysis, Profiles, Strategic Developments, Mergers, Product Innovations and Launches, Sustainability Goals, Revenues",
        "description": "",
        "summary": "The Hormone Replacement Therapy (HRT) market is poised to expand significantly from $23.58 billion in 2025 to $38.18 billion by 2033, driven by a CAGR of 6.21%. Key growth drivers include technological advancements, innovations in delivery methods, and rising cases of hormonal disorders. Increased awareness and acceptance of HRT, largely for menopause-related symptoms in women, alongside supportive government policies, further contribute to market growth. The sector sees immense potential, parti",
        "pubDate": "2026-02-24T12:01:00Z",
        "displayTime": "2026-02-24T12:01:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/72c7adc1d21ac3337819dd302cd09557",
          "originalWidth": 600,
          "originalHeight": 400,
          "caption": "Hormone Replacement Therapy Market",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/EZe35VZrgWnNtkkkHAJlPQ--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/72c7adc1d21ac3337819dd302cd09557.cf.webp",
              "width": 600,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/wXwdmyEAoh1pZFSbv_wEGA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/72c7adc1d21ac3337819dd302cd09557.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/hormone-replacement-therapy-market-competitive-120100685.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/hormone-replacement-therapy-market-competitive-120100685.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABT"
            },
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-24T13:20:00+00:00",
    "headline": "This High‑Yield Pharma Beast AbbVie Could Turn Dividends Into Life‑Changing Income",
    "summary": "AbbVie's dividend yield is far above the market's, and the dividend has been growing for years.",
    "url": "https://www.fool.com/investing/2026/02/24/high-yield-pharma-beast-abbvie-could-turn-dividend/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "d58d80f8-63d8-3086-a0de-d55fffb8fd1d",
      "content": {
        "id": "d58d80f8-63d8-3086-a0de-d55fffb8fd1d",
        "contentType": "STORY",
        "title": "This High‑Yield Pharma Beast AbbVie Could Turn Dividends Into Life‑Changing Income",
        "description": "",
        "summary": "AbbVie's dividend yield is far above the market's, and the dividend has been growing for years.",
        "pubDate": "2026-02-24T13:20:00Z",
        "displayTime": "2026-02-24T13:20:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/bd05b3d4ce814cfdb1fc5c1ebfab99bc",
          "originalWidth": 1201,
          "originalHeight": 742,
          "caption": "A gauge showing a range of income, with a finger pushing a button below it labeled with a rocket and the word Boost.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/NQ1ciKHZf3gAzpNpW3c8Xw--~B/aD03NDI7dz0xMjAxO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/bd05b3d4ce814cfdb1fc5c1ebfab99bc.cf.webp",
              "width": 1201,
              "height": 742,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/PQXzVDeJJXrZ.p7PaE65iQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/bd05b3d4ce814cfdb1fc5c1ebfab99bc.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2026/02/24/high-yield-pharma-beast-abbvie-could-turn-dividend/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/high-yield-pharma-beast-abbvie-132000672.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "INTC"
            },
            {
              "symbol": "NVDA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-24T14:00:09+00:00",
    "headline": "AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It",
    "summary": "Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock has in store.",
    "url": "https://finance.yahoo.com/news/abbvie-inc-abbv-trending-stock-140009100.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "b206bf91-24d8-3cb4-b2e9-d84999e87eb3",
      "content": {
        "id": "b206bf91-24d8-3cb4-b2e9-d84999e87eb3",
        "contentType": "STORY",
        "title": "AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It",
        "description": "",
        "summary": "Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock has in store.",
        "pubDate": "2026-02-24T14:00:09Z",
        "displayTime": "2026-02-24T14:00:09Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/432476d296d64c50172213c0415587c9",
          "originalWidth": 1000,
          "originalHeight": 603,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YgRrCYuBdR1wa08RtjoPHQ--~B/aD02MDM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/432476d296d64c50172213c0415587c9.cf.webp",
              "width": 1000,
              "height": 603,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jAWLk_UfDMDSToA2irhEEg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/432476d296d64c50172213c0415587c9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-inc-abbv-trending-stock-140009100.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-inc-abbv-trending-stock-140009100.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-24T16:15:00+00:00",
    "headline": "OTC Artificial Tears Market Competitive Landscape Report 2025: Key Players Analysis, Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Forecasts to 2033",
    "summary": "The OTC Artificial Tears market is projected to expand from USD 4.93 billion in 2025 to USD 7.22 billion by 2033, growing at a CAGR of 4.88%. This growth is driven by increased accessibility in public spaces, rising dry eye syndrome cases due to aging and digital exposure, and heightened awareness of eye health. Artificial tears mimic natural tears to relieve dry eyes, making them integral to eye care routines. Key players, including AbbVie, Akorn, Alcon, Bausch Health, and Johnson & Johnson, ar",
    "url": "https://finance.yahoo.com/news/otc-artificial-tears-market-competitive-161500184.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "c306724d-48b2-356f-a36c-8eaf1e61b9ad",
      "content": {
        "id": "c306724d-48b2-356f-a36c-8eaf1e61b9ad",
        "contentType": "STORY",
        "title": "OTC Artificial Tears Market Competitive Landscape Report 2025: Key Players Analysis, Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Forecasts to 2033",
        "description": "",
        "summary": "The OTC Artificial Tears market is projected to expand from USD 4.93 billion in 2025 to USD 7.22 billion by 2033, growing at a CAGR of 4.88%. This growth is driven by increased accessibility in public spaces, rising dry eye syndrome cases due to aging and digital exposure, and heightened awareness of eye health. Artificial tears mimic natural tears to relieve dry eyes, making them integral to eye care routines. Key players, including AbbVie, Akorn, Alcon, Bausch Health, and Johnson & Johnson, ar",
        "pubDate": "2026-02-24T16:15:00Z",
        "displayTime": "2026-02-24T16:15:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/2b73cbd5c099cf6a6244df6a13c02a7a",
          "originalWidth": 600,
          "originalHeight": 400,
          "caption": "OTC Artificial Tears Market",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/UUifFuEFTcWl4nx7c0f8Pg--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/2b73cbd5c099cf6a6244df6a13c02a7a.cf.webp",
              "width": 600,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/B27LDU15ma7.d1lEsHiznw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/2b73cbd5c099cf6a6244df6a13c02a7a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/otc-artificial-tears-market-competitive-161500184.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/otc-artificial-tears-market-competitive-161500184.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "ALC"
            },
            {
              "symbol": "BHC"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-24T11:01:38+00:00",
    "headline": "AbbVie to spend $380M on two 2 manufacturing facilities in Illinois",
    "summary": "The active pharmaceutical ingredient manufacturing facilities are part of a broader $100 billion investment commitment to strengthen the company’s U.S. manufacturing capabilities.",
    "url": "https://www.manufacturingdive.com/news/abbvie-380m-pharmaceutical-facilities-in-illinois/812867/",
    "source": "Manufacturing Dive",
    "provider": "yfinance",
    "raw": {
      "id": "2b180f35-6f4b-392e-9d6d-b57088e50d01",
      "content": {
        "id": "2b180f35-6f4b-392e-9d6d-b57088e50d01",
        "contentType": "STORY",
        "title": "AbbVie to spend $380M on two 2 manufacturing facilities in Illinois",
        "description": "",
        "summary": "The active pharmaceutical ingredient manufacturing facilities are part of a broader $100 billion investment commitment to strengthen the company’s U.S. manufacturing capabilities.",
        "pubDate": "2026-02-24T11:01:38Z",
        "displayTime": "2026-02-24T11:01:38Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/manufacturing_dive_692/851fb4e7ea2ff8b4c9e496b74f98f8d5",
          "originalWidth": 1600,
          "originalHeight": 900,
          "caption": "AbbVie logo on the facade of its headquarters in San Francisco, Calif., on July 31, 2021. ",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/yg2GiOqj07zXPXaV3JYiXw--~B/aD05MDA7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/manufacturing_dive_692/851fb4e7ea2ff8b4c9e496b74f98f8d5.cf.webp",
              "width": 1600,
              "height": 900,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/gGGxI.0.7DfXEBOBi.i2dQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/manufacturing_dive_692/851fb4e7ea2ff8b4c9e496b74f98f8d5.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Manufacturing Dive",
          "url": "https://www.manufacturingdive.com/"
        },
        "canonicalUrl": {
          "url": "https://www.manufacturingdive.com/news/abbvie-380m-pharmaceutical-facilities-in-illinois/812867/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-spend-380m-two-manufacturing-110138956.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]